התחל במצב לא מקוון עם האפליקציה Player FM !
Impact of Time of Day of Immune Checkpoint Inhibitor Infusion on Overall Survival in Advanced Melanoma
סדרה בארכיון ("עדכון לא פעיל" status)
When? This feed was archived on June 25, 2023 07:37 (). Last successful fetch was on May 05, 2023 17:56 ()
Why? עדכון לא פעיל status. השרתים שלנו לא הצליחו לאחזר פודקאסט חוקי לזמן ממושך.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 310003121 series 2572233
On this episode, we’ll hear about a study that examined the impact of the time of day that a patient with advanced melanoma receives an immune checkpoint inhibitor infusion on overall survival. Then, we’ll hear about two recent approvals from the FDA—one in relapsed or refractory multiple myeloma, and one for identification of ovarian cancer lesions during surgery.
Coverage of stories discussed this week on ascopost.com:
FDA Approves Pafolacianine to Help Identify Ovarian Cancer Lesions
To listen to more podcasts from ASCO, visit asco.org/podcasts.
185 פרקים
סדרה בארכיון ("עדכון לא פעיל" status)
When? This feed was archived on June 25, 2023 07:37 (). Last successful fetch was on May 05, 2023 17:56 ()
Why? עדכון לא פעיל status. השרתים שלנו לא הצליחו לאחזר פודקאסט חוקי לזמן ממושך.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 310003121 series 2572233
On this episode, we’ll hear about a study that examined the impact of the time of day that a patient with advanced melanoma receives an immune checkpoint inhibitor infusion on overall survival. Then, we’ll hear about two recent approvals from the FDA—one in relapsed or refractory multiple myeloma, and one for identification of ovarian cancer lesions during surgery.
Coverage of stories discussed this week on ascopost.com:
FDA Approves Pafolacianine to Help Identify Ovarian Cancer Lesions
To listen to more podcasts from ASCO, visit asco.org/podcasts.
185 פרקים
כל הפרקים
×ברוכים הבאים אל Player FM!
Player FM סורק את האינטרנט עבור פודקאסטים באיכות גבוהה בשבילכם כדי שתהנו מהם כרגע. זה יישום הפודקאסט הטוב ביותר והוא עובד על אנדרואיד, iPhone ואינטרנט. הירשמו לסנכרון מנויים במכשירים שונים.